Urothelial Cancer Preceptorship
The therapeutic landscape for urothelial cancer has undergone significant transformation...
The therapeutic landscape for urothelial cancer has undergone significant transformation...
Coming Soon
An ACE Oncology Satellite Symposium in conjunction with the 2022...
One of ASCO 2022’s most headline-grabbing presentations included results from...
The 2022 ASCO Annual Meeting was held during 3 –...
The US FDA approved seven new indications for cancer management...
The combination of neoadjuvant nivolumab and platinum doublet chemotherapy was...